RKDA · Arcadia Biosciences, Inc.
$0.51
-0.03 (-4.72%)
At close · Aug 31
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these condensed consolidated financial statements, which raises substantial doubt about the Company's ability to continue as a going concern, and the audit opinion on our 2025 audited consolidated financial statements includes a going concern explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$1.28M
Shares
2.41M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Thomas J. Schaefer | President and Chief Executive Officer | $469,001 |
| Mark Kawakami | Former Chief Financial Officer | $218,425 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Stanley E. Jacot | Former President and Chief Executive Officer | $518,108 |
| Thomas J. Schaefer | President and Chief Executive Officer | $499,477 |
| Thomas Schaefer | CEO | $499,477 |
| Mark Kawakami | Former Chief Financial Officer | $370,175 |
| Laura Pitlik | Former Chief Marketing Officer | $154,826 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Stanley E. Jacot | Former President and Chief Executive Officer | $525,177 |
| Thomas Schaefer | CFO | $380,538 |
| Thomas J. Schaefer | President and Chief Executive Officer | $380,538 |
| Laura Pitlik | Former Chief Marketing Officer | $346,271 |
| Mark Kawakami | Former Chief Financial Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Stanley E. Jacot | President and Chief Executive Officer | $749,467 |
| Laura Pitlik | Former Chief Marketing Officer | $452,915 |
| Pamela Haley | Former Chief Financial Officer | $408,503 |
| Kevin Comcowich | — | $208,088 |
| Thomas Schaefer | CFO | — |
| Thomas J. Schaefer | Chief Financial Officer | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Matthew Plavan | Former President and Chief Executive Officer | $1,606,004 |
| Chris Cuvelier | Chief Growth Officer | $535,655 |
| Pamela Haley | Former Chief Financial Officer | $474,416 |
| Laura Pitlik | Chief Marketing Officer | $343,307 |
| Stanley E. Jacot | President and Chief Executive Officer | — |
| Former Interim Chief | Executive Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Matthew Plavan | Former President and Chief Executive Officer | $794,148 |
| Sarah Reiter | Former Chief Commercial Officer | $527,155 |
| Pamela Haley | Chief Financial Officer | $443,191 |
| Randall Shultz | Chief Technology Officer | $431,480 |
| Chris Cuvelier | Chief Growth Officer | — |
| Laura Pitlik | Chief Marketing Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Matthew Plavan | President and Chief Executive Officer | $581,078 |
| Rajendra Ketkar | Former President and Chief Executive Officer | $562,428 |
| Sarah Reiter | Former Chief Commercial Officer | $456,392 |
| Randall Shultz | Chief Technology Officer | $339,564 |
| Pamela Haley | Chief Financial Officer | $285,035 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Rajendra Ketkar | Former President and Chief Executive Officer | $904,484 |
| Sarah Reiter | Chief Commercial Officer | $782,740 |
| Matthew Plavan | President and Chief Executive Officer | $583,010 |
| Pamela Haley | Chief Financial Officer | $233,894 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Deborah Carosella | director | Resigned | 2026-02-06 |
| Albert D. Bolles, Ph.D. | director | Resigned | 2026-02-06 |
| Mark Kawakami | principal accounting officer | Resigned | 2025-08-29 |
| Mark Kawakami | chief financial officer and principal accounting officer | Resigned | 2025-08-29 |
| Stanley Jacot | director | Resigned | 2024-08-07 |
| Thomas J. Schaefer | Class I director | Appointed | 2024-08-07 |
| Mark Kawakami | chief financial officer | Appointed | 2024-07-08 |
| Thomas J. Schaefer | president and chief executive officer | Appointed | 2024-07-08 |
| Stanley Jacot, Jr. | president, chief executive officer and director | Resigned | 2024-07-08 |
| Laura Pitlik | chief marketing officer | Resigned | 2024-02-14 |
| Thomas J. Schaefer | chief financial officer | Appointed | 2022-11-30 |
| Pamela Haley | chief financial officer | Resigned | 2022-11-30 |
| Stanley E. Jacot, Jr. | Class III director | Appointed | 2022-06-07 |
| Stan Jacot | chief executive officer | Appointed | 2022-02-07 |
| Kevin Comcowich | interim president and chief executive officer | Resigned | 2022-02-07 |
| Stanley Jacot, Jr. | president and chief executive officer | Appointed | 2022-02-07 |
| Kevin Comcowich | Interim Chief Executive Officer | Appointed | 2021-12-20 |
| Matt Plavan | member of the Board of Directors | Resigned | 2021-12-20 |
| Matt Plavan | Chief Executive Officer | Resigned | 2021-12-20 |
| Chris Cuvelier | Chief Growth Officer | Terminated | 2021-11-19 |
| Laura Pitlik | Chief Marketing Officer | Appointed | 2021-07-20 |
| Debbie Carosella | director | Appointed | 2021-02-24 |
Key facts
CIK
1469443
CUSIP
039014303
13F (30d)
16 filings
16 filers
Visit website
Investor relations